RFI - Molecular test for detection and/or quantification of hepatitis virus A, B, C, D and E

Information

Prior information notice to reduce time limits
01 - Prior information notice
3/30/2023 2:20 PM (GMT+02:00)
No

Buyer

Norsk Helsenett SF Norsk Helsenett SF
Brian Mariampillai Brian Mariampillai
Abels gate 9
Postboks 6123, 7435 TRONDHEIM

7030 TRONDHEIM
Norway
994598759

Short description

The Norwegian Institute of Public Health (NIPH) plan to acquire molecular test for detection and/or quantification of hepatitis virus (A, B, C, D and E) certified in according to the new EU IVDR regulations that will apply from May 2025 (class D).

The virology department at the Norwegian Institute of Public Health is reference laboratory for hepatitis virus in Norway, and hence offer primary, confirmational or supplementary analysis primarily to the microbial laboratories around Norway. The number of samples are generally low compared to the primary microbial laboratories, and varies over time, depending on the demand and ongoing projects. There is therefore a need for a small and flexible system, preferably with automated extraction.

In this regard we would like to have information of test that are or will soon be available on the marked, as well as their specifications. This is in preparation for a tender.

Files (click "Show interest" to get access)

Mercell Holding AS

Part of the Mercell Group, one of Europe’s leading providers of e tender systems and information between buyers and suppliers in the professional market.

Contact us

Write to us

+47 21 01 88 00